OKAY
833230
CHANGFU CO.,LTD
871396
Gansu Longshenrongfa Pharmaceutical Industry
300534
4
Tibet Duo Rui Pharmaceutical
301075
5
Chengda Pharmaceuticals
301201
CN Stock MarketDetailed Quotes
000001 Ping An Bank
- 11.27
- +0.01+0.09%
Not Open Apr 1 15:00 CST
218.70BMarket Cap4.91P/E (TTM)
11.30High11.22Low681.47KlotVolume11.27Open11.26Pre Close767.42MTurnover0.35%Turnover Ratio4.91P/E (Static)19.41BShares13.1852wk High0.51P/B218.70BFloat Cap9.0852wk Low12.39Limit Up19.41BShs Float23.68Historical High10.13Limit Down0.71%Amplitude-2.42Historical Low0.97Dividend TTM11.26Avg Price341.79KlotAsk8.56%Div YieldTTM100Lot Size328.57KlotBid
Ping An Bank Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating revenue | -10.93%146.7B | -12.58%111.58B | -12.95%77.13B | -14.03%38.77B | -8.45%164.7B | -7.69%127.63B | -3.71%88.61B | -2.40%45.1B | 6.21%179.9B | 8.71%138.27B |
| Net interest income | -20.82%93.43B | -20.60%72.54B | -21.63%49.09B | -21.67%25.16B | -9.33%117.99B | -6.16%91.36B | -2.22%62.63B | 0.54%32.12B | 8.14%130.13B | 8.70%97.35B |
| -Interest income | -12.84%198.38B | -11.36%153.3B | -10.59%104.13B | -9.07%53.37B | -0.55%227.62B | 1.45%172.96B | 3.26%116.47B | 4.19%58.69B | 7.18%228.88B | 7.44%170.49B |
| -Less:Interest expense | -4.26%104.95B | -1.02%80.77B | 2.25%55.04B | 6.15%28.21B | 11.02%109.63B | 11.56%81.6B | 10.47%53.83B | 8.97%26.58B | 5.95%98.75B | 5.81%73.14B |
| Net commission income | -18.07%24.11B | -18.47%18.71B | -20.62%13B | -19.11%7.18B | -2.58%29.43B | 2.47%22.95B | 1.94%16.37B | -0.10%8.88B | -8.63%30.21B | -11.96%22.4B |
| -Commission income | -20.54%27.84B | -20.62%21.55B | -22.56%14.93B | -20.74%8.22B | -7.18%35.04B | -3.22%27.15B | -1.63%19.28B | -3.45%10.37B | -6.06%37.75B | -8.89%28.05B |
| -Less:Commission expense | -33.50%3.73B | -32.40%2.84B | -33.46%1.94B | -30.44%1.04B | -25.63%5.61B | -25.78%4.2B | -17.85%2.91B | -19.52%1.49B | 5.86%7.55B | 5.72%5.66B |
| Invest income | 53.26%24.6B | 63.07%18.37B | 67.96%12.24B | 42.36%4.7B | 21.23%16.05B | 4.14%11.27B | -6.20%7.29B | -14.83%3.3B | 8.17%13.24B | 15.49%10.82B |
| Exchange income | 32.93%880M | -85.81%111M | -92.00%56M | -97.78%7M | -85.44%662M | -81.02%782M | -67.92%700M | -52.34%315M | 244.55%4.55B | 315.01%4.12B |
| Asset deal income | -94.44%8M | -101.59%-1M | -65.67%23M | -57.14%3M | -20.00%144M | -47.50%63M | -34.31%67M | -91.03%7M | 1,400.00%180M | 531.58%120M |
| Other revenue | -23.93%178M | -36.97%133M | -40.72%115M | -64.74%61M | 8.84%234M | 50.71%211M | 48.09%194M | 260.42%173M | -4.44%215M | -30.35%140M |
| Operating payout | -11.78%42.06B | -9.88%31.7B | -9.95%21.89B | -11.78%10.82B | -6.72%47.68B | -6.97%35.17B | -3.59%24.31B | -2.22%12.27B | 3.09%51.11B | 3.31%37.81B |
| Operating and admin expense | -11.70%40.58B | -9.77%30.58B | -9.94%21.11B | -11.66%10.43B | -6.94%45.96B | -7.20%33.89B | -3.74%23.44B | -2.47%11.81B | 3.02%49.39B | 3.25%36.52B |
| Operating tax surcharges | -13.91%1.48B | -12.61%1.12B | -10.41%783M | -14.85%390M | -0.52%1.72B | -0.46%1.29B | 0.81%874M | 4.57%458M | 5.05%1.73B | 5.04%1.29B |
| Credit Impairment Loss | 17.08%-48.94B | 26.11%-32.01B | 28.37%-23.15B | 34.98%-9.4B | 17.27%-59.02B | 20.06%-43.33B | 16.90%-32.32B | 16.62%-14.45B | 1.76%-71.34B | -3.06%-54.2B |
| Asset Impairment Loss | -535.06%-489M | 98.86%-1M | 94.87%-2M | 93.33%-1M | -320.00%-77M | -351.43%-88M | -179.59%-39M | -350.00%-15M | 102.92%35M | 102.97%35M |
| Operating profit | -4.70%55.21B | -2.40%47.87B | 0.47%32.09B | 1.01%18.55B | 0.79%57.93B | 5.94%49.05B | 14.22%31.94B | 12.42%18.37B | 24.99%57.48B | 25.70%46.3B |
| Add:Nonoperating income | -24.49%37M | -16.13%26M | -9.09%20M | 9.09%12M | -23.44%49M | -38.00%31M | -24.14%22M | -21.43%11M | -59.49%64M | -40.48%50M |
| Less:Nonoperating expense | 94.98%505M | 77.65%151M | 400.00%130M | 215.38%41M | -9.44%259M | -63.52%85M | -87.44%26M | -92.35%13M | 8.33%286M | 84.92%233M |
| Total profit | -5.16%54.74B | -2.55%47.74B | 0.14%31.98B | 0.86%18.53B | 0.81%57.72B | 6.25%48.99B | 14.94%31.93B | 13.49%18.37B | 24.79%57.25B | 25.35%46.11B |
| Less:Income tax cost | -9.17%10.23B | -14.35%8.02B | -6.84%6.1B | -4.57%3.59B | -4.04%11.26B | -1.00%9.36B | 14.94%6.55B | 12.93%3.77B | 22.99%11.74B | 23.54%9.45B |
| Net profit | -4.19%44.51B | 0.24%39.73B | 1.94%25.88B | 2.26%14.93B | 2.06%46.46B | 8.12%39.64B | 14.94%25.39B | 13.63%14.6B | 25.26%45.52B | 25.82%36.66B |
| Net profit from continuing operation | -4.19%44.51B | 0.24%39.73B | 1.94%25.88B | 2.26%14.93B | 2.06%46.46B | 8.12%39.64B | 14.94%25.39B | 13.63%14.6B | 25.26%45.52B | 25.82%36.66B |
| Net profit of parent company owners | -4.19%44.51B | 0.24%39.73B | 1.94%25.88B | 2.26%14.93B | 2.06%46.46B | 8.12%39.64B | 14.94%25.39B | 13.63%14.6B | 25.26%45.52B | 25.82%36.66B |
| Earning per share | ||||||||||
| Basic earning per share | -4.44%2.15 | 0.00%1.94 | 2.50%1.23 | 1.54%0.66 | 2.27%2.25 | 8.99%1.94 | 16.50%1.2 | 16.07%0.65 | 27.17%2.2 | 27.14%1.78 |
| Diluted earning per share | -4.44%2.15 | 0.00%1.94 | 2.50%1.23 | 1.54%0.66 | 2.27%2.25 | 8.99%1.94 | 16.50%1.2 | 16.07%0.65 | 27.17%2.2 | 27.14%1.78 |
| Other composite income | -0.54%-374M | 6.21%-786M | 5.07%-356M | 177.01%345M | -137.58%-372M | -211.52%-838M | -136.91%-375M | -376.60%-448M | -25.17%990M | -124.15%-269M |
| Total composite income | -4.23%44.13B | 0.38%38.94B | 2.04%25.52B | 7.93%15.28B | -0.91%46.08B | 6.61%38.8B | 8.26%25.01B | 10.96%14.15B | 23.49%46.51B | 20.30%36.39B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.